Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — GENI

Balance Sheet

(in billions USD)

Metric	Q4 2025	Q4 2024	Q4 2023	Q2 2023	Q4 2022	Q4 2021
Cash & Equivalents	0.28	0.11	0.10	0.09	0.12	0.22
Accounts Receivable	0.13	0.09	0.07	0.06	0.03	0.05
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Assets	0.55	0.29	0.24	0.22	0.24	0.32
Property, Plant & Equipment	0.03	0.02	0.01	0.01	0.01	0.01
Goodwill	0.34	0.33	0.33	0.32	0.31	0.35
Intangible Assets	0.14	0.12	0.13	0.14	0.15	0.19
Total Non-current Assets*	0.00	0.00	0.53	0.55	0.54	0.56
Total Assets	1.13	0.79	0.78	0.77	0.77	0.89
Accounts Payable	0.11	0.04	0.06	0.02	0.03	0.02
Total Current Liabilities	0.35	0.20	0.18	0.15	0.17	0.15
Long-term Debt	--	0.00	0.01	0.01	0.01	0.00
Total Non-current Liabilities*	0.05	0.02	0.02	0.02	0.03	0.03
Total Liabilities	0.41	0.22	0.20	0.17	0.20	0.18
Retained Earnings	(1.20)	(1.09)	(1.02)	(0.97)	(0.94)	(0.76)
Total Stockholder Equity	0.72	0.57	0.57	0.60	0.58	0.71

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2023
Total Revenue	86.85
Cost of Revenue	62.17
Gross Profit	24.67
Research & Development	5.81
Selling, General & Admin	19.62
Total Operating Expenses	32.52
Operating Income	(7.84)
Pretax Income	(6.90)
Tax Provision	3.95
Net Income	(10.30)
Basic EPS	(0.05)
Diluted EPS	(0.05)

← Scroll for more columns →

Cash Flow Statement

(in millions USD)

Metric	Q2 2023
Operating Cash Flow	(22.71)
Capital Expenditures	1.00
Free Cash Flow*	(23.71)
Investing Cash Flow	(20.89)
Financing Cash Flow	(0.58)

← Scroll for more columns →

* Derived from reported values